Company Filing History:
Years Active: 2022-2025
Title: The Innovative Journey of Colin Ng in Cellular Analysis
Introduction
Colin Ng is an accomplished inventor based in Branford, CT, known for his significant contributions to the field of cellular analysis. With a portfolio that includes four patents, Colin has developed groundbreaking methods and systems that enhance the capabilities of immunotherapeutic applications.
Latest Patents
Among Colin's latest patents is a system and methods for multiplexed analysis of cellular and other immunotherapeutics. This innovation discloses methods that identify a secretome from a subject cell within a heterogeneous cell population, particularly focusing on interactions between immune cells and cancer cells. This work is pivotal in creating safer and more effective cellular therapies including adoptive CAR T-cell therapies.
Another notable patent of Colin’s is centered on compositions and methods for the simultaneous genomic, transcriptomic, and proteomic analysis of single cells. This patent presents innovative compositions and methods that allow multiplexed analysis of intracellular targets in single cells, promising advancements in cellular research and therapeutic development.
Career Highlights
Colin Ng has made substantial strides in his career at Isoplexis Corporation, a company dedicated to advancing the capability of precision medicine through innovative cellular analysis technologies. His role at the company has positioned him as a key player in the research and development of cutting-edge solutions that empower biomedical research.
Collaborations
Throughout his professional journey, Colin has collaborated with talented individuals, including his coworkers Sean MacKay and Alaina Kaiser. Their joint efforts have led to significant advancements in their respective fields, enhancing the overall impact of their work on cellular technologies.
Conclusion
Colin Ng represents the spirit of innovation in the field of cellular analysis, consistently pushing the boundaries of what is possible in immunotherapeutics. His contributions, particularly through his patents, demonstrate a commitment to improving healthcare through scientific discovery and engineering excellence. Colin’s work continues to inspire and shape the future of cellular therapies, providing valuable resources for researchers and developers alike.